Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of ...
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between ...
Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage ...
Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicinesVANCOUVER, British Columbia--(BUSINESS ...
Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End MarketsExpands Mechanical Services ...
Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 ...
Biogen will acquire Apellis for 5.6 billion dollars, adding two approved therapies and boosting growth in immunology and ...
Care Market OverviewThe global digital musculoskeletal (MSK) care market is poised for robust expansion, with an anticipated ...
New PDUFA Target Action Date of July 6, 2026 allows FDA additional time to complete its reviewMENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to ...
CNX Therapeutics Limited ("CNX Therapeutics"), a specialty pharmaceutical company focused on improving patient access to essential medicines, today announced it has acquired the rights to Tacrolimus 5 ...
Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results